Lisata Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Lisata Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

H.C. Wainwright Reiterates Buy Rating on Lisata Therapeutics, Inc (LSTA)

August 13, 2024 6:04 AM EDT

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating and $15.00 price target on Lisata Therapeutics, Inc (NASDAQ: LSTA).

The analyst comments "Financial and corporate update. Yesterday after the close, Lisata announced 2Q24 financial results, posting EPS of ($0.61) compared to our estimate of ($0.76)... More